New CD20 alternative splice variants: molecular identification and differential expression within hematological B cell malignancies

BACKGROUND: CD20 is a B cell lineage–specific marker expressed by normal and leukemic B cells and targeted by several antibody immunotherapies. We have previously shown that the protein from a CD20 mRNA splice variant (D393-CD20) is expressed at various levels in leukemic B cells or lymphoma B cells...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Exp Hematol Oncol
Autores principales: Gamonet, Clémentine, Bole-Richard, Elodie, Delherme, Aurélia, Aubin, François, Toussirot, Eric, Garnache-Ottou, Francine, Godet, Yann, Ysebaert, Loïc, Tournilhac, Olivier, Caroline, Dartigeas, Larosa, Fabrice, Deconinck, Eric, Saas, Philippe, Borg, Christophe, Deschamps, Marina, Ferrand, Christophe
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4774009/
https://ncbi.nlm.nih.gov/pubmed/26937306
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40164-016-0036-3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares